Asako Nishimura
- Oncology
- Biomaterials
- Molecular Biology
- Pediatrics, Perinatology and Child Health
- Pharmacology top 10%
- Co-authors
- Nobuhito ShibataNobuyuki SugiokaKeizo FukushimaKanji TakadaYukako ΙtοKazumasa NaruhashiAkiko KiriyamaTaro Hayakawa
- Topics
- Pharmacological Effects and Toxicity Studies (8 papers)Drug Transport and Resistance Mechanisms (6 papers)Cancer Treatment and Pharmacology (4 papers)
- Journals
- International Journal of PharmaceuticsJournal of Pharmaceutical SciencesBiomedicine & Pharmacotherapy
- Partner nations
- JapanGermanyUnited States
In The Last Decade
Asako Nishimura
28 papers receiving 406 citations
Peers
Comparison fields: 5 of 86
- Oncology 134
- Biomaterials 88
- Molecular Biology 72
- Pediatrics, Perinatology and Child Health 72
- Pharmacology 56
Countries citing papers authored by Asako Nishimura
This map shows the geographic impact of Asako Nishimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asako Nishimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asako Nishimura more than expected).
Fields of papers citing papers by Asako Nishimura
This network shows the impact of papers produced by Asako Nishimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asako Nishimura. The network helps show where Asako Nishimura may publish in the future.
Co-authorship network of co-authors of Asako Nishimura
This figure shows the co-authorship network connecting the top 25 collaborators of Asako Nishimura. A scholar is included among the top collaborators of Asako Nishimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asako Nishimura. Asako Nishimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 20 | |
| 2 | 14 | |
| 3 | 12 | |
| 4 | 2 | |
| 5 | 19 | |
| 6 | 23 | |
| 7 | 17 | |
| 8 | 9 | |
| 9 | 11 | |
| 10 | 42 | |
| 11 | 9 | |
| 12 | 6 | |
| 13 | 1 | |
| 14 | 33 | |
| 15 | 19 | |
| 16 | 1 | |
| 17 | 29 | |
| 18 | 12 | |
| 19 | 12 | |
| 20 | 3 |
About Asako Nishimura
Asako Nishimura is a scholar working on Transplantation, Oncology and Pediatrics, Perinatology and Child Health, having authored 30 papers that have together received 414 indexed citations. Recurring topics across this work include Pharmacological Effects and Toxicity Studies (8 papers), Drug Transport and Resistance Mechanisms (6 papers) and Cancer Treatment and Pharmacology (4 papers). The work is most often cited by research in Biomaterials (88 citations), Transplantation (18 citations) and Pharmacology (56 citations). Asako Nishimura has collaborated with scholars based in Japan, Germany and United States. Frequent co-authors include Nobuhito Shibata, Nobuyuki Sugioka, Keizo Fukushima, Kanji Takada, Yukako Ιtο, Kazumasa Naruhashi, Akiko Kiriyama, Taro Hayakawa, Akira Okada and Katsukuni Fujimoto. Their work appears in journals such as International Journal of Pharmaceutics, Journal of Pharmaceutical Sciences and Biomedicine & Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.